The Canadian Academy of Health Sciences (CAHS) and the Royal Society of Canada (RSC) have established an expert panel to assess Canada’s role in global health and to identify opportunities for Canada to enhance its leadership.
There are crucial questions related to Canada’s global health “footprint”: What impact has the pandemic had on Canada’s engagement in global health? What are some of the urgent next steps as we emerge from the pandemic, such that Canada can be true to its announced values of equity, human rights, and global citizenship?
The expert panel will study the history of Canada’s engagement in global health, the recent period including the COVID-19 pandemic, and future opportunities for Canada’s to play a leadership role as a middle power.
Working Group:
Tim Evans
Dr. Timothy Grant Evans joined McGill University in September 2019, as the Inaugural Director and Associate Dean of the School of Population and Global Health (SPGH) in the Faculty of Medicine and Associate Vice-Principal (Global Policy and Innovation). Since joining McGill, and in the context of the COVID-19 Pandemic, he was named as the Executive Director of Canada’s COVID-19 Immunity Task Force in April 2020. |
|
Kelley Lee Dr. Lee’s research focuses on strengthening collective action to manage health risks arising from a globally interconnected world. She heads the Pandemics and Borders Project on use of travel measures during the COVID-19 pandemic. |
|
Chantal Blouin Dr. Blouin is a political scientist whose research is investigating how to harness public policies and global governance to improve health and prevent chronic diseases. |
|
Jocalyn Clark Dr Jocalyn Clark is a Canadian public health scientist and International Editor of The BMJ in London, UK, whose work advances gender equity, global health, and Canadian perspectives in an international context. |
|
Robert Greenhill
Robert Greenhill is Executive Chairman, Global Canada Initiative, and Professor of Practice at the Institute for the Study of International Development, McGill University. With a strong interest in global issues, Robert has combined a career in international business with a commitment to public policy. |
|
Joanne Liu
Dr. Liu is a Canadian practicing paediatric emergency physician and professor at McGill University’s School of Population & Global Health where she focuses on pandemic and health emergencies. |
|
Jane Philpott
Jane Philpott is Dean of Health Sciences and Director of the School of Medicine at Queen’s University. She is a Professor of Family Medicine and former Member of Parliament. From 2015 to 2019 she served as federal Minister of Health, Minister of Indigenous Services, and President of the Treasury Board. |
|
K. Srinath Reddy
Prof. Reddy’s research has focused on prevention and control of non-communicable diseases in India and globally, health promotion in school and worksite settings, health system strengthening for delivering universal health coverage, impact of air pollution and climate change on human health. He has built public health capacity in India, for multi-disciplinary education and research, by establishing five Indian Institutes of Public Health. |
|
Francis Omaswa
Francis Omaswa, is founder and ED of the African Center for Global Health and Social Transformation in Uganda. He has a passion for pro-poor health systems and services and has used his global health networks to advance health workforce policies and strategies that enable all people to access skilled, motivated and supported health workers. |
|
Nadine Caron |
Expert Panel Secretariat:
Prativa Baral
Prativa Baral is an epidemiologist and a PhD candidate at Johns Hopkins School of Public Health, focusing on health systems resilience, global preparedness against health emergencies, and global health policy in the context of crises. |
|
Gatien de Broucker
Gatien de Broucker is a health economist and a Ph.D. student at Johns Hopkins Bloomberg School of Public Health. He investigates the economic burden of disease, highlighting patients’ and their caregivers’ experiences as we generate crucial data to plan and prioritize public health interventions. |
|
Daniel Eisenkraft Klein
Daniel Eisenkraft Klein is a PhD Candidate at the University of Toronto. His research explores the politics of health policy-making and the commercial determinants of health. |
|
Leah Shipton
Leah Shipton is a PhD Candidate at the University of British Columbia. She studies the roles and influence of non-state actors in global health and environmental governance, with a particular interest in multi-stakeholder partnerships. |